Forbion Capital Partners (“Forbion”), one of the leading Dutch Venture Capital firms investing in world-class healthcare technologies, today announced its investment, as lead investor, in Akarna Therapeutics Ltd (“Akarna”), a privately held biopharmaceutical company.